Translyx
Partner network

Your bridge to New Zealand and Oceania healthcare.

Translyx partners with global diagnostic and clinical-AI innovators — bringing world-class technology to New Zealand and Oceania with local expertise, governance, and clinical adoption. Aiforia and Algoscope are our current partner products.

Why partner with Translyx

A trusted local partner for global innovators.

Bringing diagnostic and AI technology into a new region takes more than distribution. Translyx provides the clinical, regulatory, and operational bridge to adopt it well.

Market access

Direct reach into hospitals, laboratories, pathology groups, and research teams across New Zealand and Oceania.

Clinical & regulatory navigation

Local expertise to position technology appropriately — careful compliance and no implied regulatory endorsement.

Governed adoption

Reviewer-gated, privacy-first deployment so clinical AI is adopted with confidence and human oversight.

Implementation & support

Hands-on evaluation, onboarding, training, and ongoing local support across clinical and research settings.

Distribution & logistics

Operational, supply, and logistics support for diagnostic products entering the region.

A trusted local entity

An accountable New Zealand company representing your brand to local healthcare and research organisations.

Our partners

Our clinical technology partners.

Active partner

Authorised Partner Solution

Aiforia Technologies Plc

Digital Pathology AIHelsinki, Finland

AI-assisted digital pathology for clinical, preclinical, and research workflows. Represented by Translyx in New Zealand as an authorised business partner.

Explore Aiforia
Active partner

Partner Product

Algoscope

Surgical pathology workflow automationFrance

AI-powered workflow automation and traceability across surgery-to-pathology pathways — computer vision, 3D modelling, and pre-analytical workflow intelligence. Represented by Translyx in New Zealand.

Explore Algoscope

Aiforia and Algoscope are partner products Translyx brings to New Zealand — not owned or developed by Translyx. Product-specific regulatory status should be confirmed with each partner and the relevant regulatory authorities.

Become a partner

Bring your innovation to New Zealand and Oceania.

If you build diagnostic technology, digital pathology AI, or protected clinical software, Translyx can be your accountable local partner — handling clinical positioning, governance, adoption, and implementation across the region.